billconference

130 results found.

Top Stocks matching your search for "bill conference"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 6, 2023

$AVXL thanks yet again Bill.

Dec, 9, 2022

Worth the risk with patience and not investing lif... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TLRY

Tilray Brands Inc - Ordinary Shares - Class 2

-15.29%

$3.14 - $2.66

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 24, 2023

So many good news coming in NOW more and more Repu... See more

Jan, 13, 2023

They’ve been the most solid supplier, and to my s... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
VLON

Vallon Pharmaceuticals Inc

49.05%

$0.28 - $0.41

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 13, 2023

If we pass this today we are going much much higher!

Feb, 13, 2023

$VLON I feel Will pass 2 dollars πŸ’΅

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 6, 2023

$AVXL thanks yet again Bill.

Dec, 9, 2022

Worth the risk with patience and not investing lifestyle or bill money.

Dec, 9, 2022

But, after cognition tests the trial passed all endpoints!

Dec, 9, 2022

THEN they said it hadnt passed any trials, well gee whiz now met BOTH secondary Endpoints. Newsflash.

Dec, 9, 2022

Blarcamesine passed every endpoints. .

Dec, 7, 2022

Key is we passed all endpoints with statically significant results!

Dec, 7, 2022

Hahah .. passed easily!

Dec, 3, 2022

Passed it all no problem!

Oct, 20, 2022

After TLR, Anavex will be the owner of a first-in-class, patented, medically-proven, high-demand asset that merely needs to pass through the technicality of government approval to qualify it for mass marketing.

TLRY

Tilray Brands Inc - Ordinary Shares - Class 2

-15.29%

$3.14 - $2.66

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 24, 2023

So many good news coming in NOW more and more Republicans filing their own weed bills like this.

Jan, 13, 2023

They’ve been the most solid supplier, and to my surprise, temporarily passed HEXO in volume of sales.

Jan, 13, 2023

once we pass $1.57 and get into the .60's we jump FAST and it's a straight shot to $1.88 $CGC $ACB $TLRY $SPCE

Jan, 11, 2023

$CRON This is good sign that under Mccarthy republicans and democrats can work together on some bills both party has support.

Jan, 9, 2023

$TLRY The best news was they almost double their Alcohol revenue and that does not depend on any legislation.

Jan, 5, 2023

THIS IS GOOD for weed bill's, like possible concession to pass important weed bill like safe banking act with LESS SOCIALIST EQUITY BS.

Jan, 5, 2023

This has bipartisan support, and it provides Republicans cover by allowing them to argue that they don’t support marijuana; rather, they are making Americans safer.

Dec, 20, 2022

It’ll make SAFE a moot bill and instantly set the sector on the path it should be taking right now…which is exponentially up from where it’s floundering now.

Dec, 18, 2022

We owe Daines a debt of gratitude for his persistence in pressing forward with his bipartisan bill.

VLON

Vallon Pharmaceuticals Inc

49.05%

$0.28 - $0.41

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 13, 2023

If we pass this today we are going much much higher!

Feb, 13, 2023

$VLON I feel Will pass 2 dollars πŸ’΅